Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Bellerophon Therapeutics, Inc. | 291,865 | reported | 07 Jun 2023 | tx 18+3,304,856 |
| AVADEL PHARMACEUTICALS PLC | 0 | reported | 12 Feb 2026 | tx 9+93,500−93,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 22,000 | 21.00 USD | |
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 11,000 | — | deriv |
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 11,000 | — | deriv |
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 49,500 | — | deriv |
| 29 Jul 2025 | GRANT_AWARD | AVADEL PHARMACEUTICALS PLC | 11,000 | 0.00 USD | |
| 29 Jul 2025 | GRANT_AWARD | AVADEL PHARMACEUTICALS PLC | 11,000 | 0.00 USD | deriv |
| 30 Jul 2024 | GRANT_AWARD | AVADEL PHARMACEUTICALS PLC | 11,000 | 0.00 USD | |
| 30 Jul 2024 | GRANT_AWARD | AVADEL PHARMACEUTICALS PLC | 11,000 | 0.00 USD | deriv |
| 17 May 2024 | GRANT_AWARD | AVADEL PHARMACEUTICALS PLC | 49,500 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 47,578 | 0.00 USD | |
| 10 Feb 2023 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 84,000 | 0.00 USD | |
| 31 Dec 2021 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 39,032 | 0.00 USD | |
| 31 Dec 2021 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 8,671 | 3.10 USD | deriv |
| 10 Sept 2020 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 6,509 | 10.12 USD | deriv |
| 26 Sept 2019 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 46,266 | 0.00 USD | deriv |
| 25 Jan 2019 | PURCHASE | Bellerophon Therapeutics, Inc. | 571,429 | 0.70 USD | first after silence |
| 21 Jun 2018 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 17,124 | 0.00 USD | |
| 05 Jun 2018 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 38,216 | 2.27 USD | deriv |
| 29 Sept 2017 | PURCHASE | Bellerophon Therapeutics, Inc. | 456,432 | — | |
| 29 Sept 2017 | PURCHASE | Bellerophon Therapeutics, Inc. | 456,432 | — | deriv |
| 22 Sept 2017 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 28 Jun 2017 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 36,232 | 0.00 USD | |
| 29 Nov 2016 | PURCHASE | Bellerophon Therapeutics, Inc. | 714,285 | — | |
| 29 Nov 2016 | PURCHASE | Bellerophon Therapeutics, Inc. | 714,285 | — | deriv |
| 17 Jun 2016 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 25 Jan 2019.